Clinical Trial Update: To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and efficacy of teriflunomide in relapsing forms of multiple sclerosis after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Relapsing Multiple Sclerosis | Phase 4 | Status: COMPLETED